Methotrexate Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2.5 mg, 10 mg, 25 mg
Reference Brands: Trexall (US)
Category: Arthritis
Methotrexate tablets inhibit dihydrofolate reductase, disrupting DNA synthesis and cell reproduction. It reduces inflammation and immune activity, making it effective for rheumatoid arthritis, psoriasis, and certain cancers. Benefits include disease modulation, improved joint function, rapid onset, and versatility, with a well-established safety profile when properly monitored. Methotrexate Tablet is available in Tablets and strengths such as 2.5 mg, 10 mg, 25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Methotrexate Tablet is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Methotrexate Tablet can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Methotrexate tablets are approved in the EU and US for treating rheumatoid arthritis, psoriasis, and certain cancers. In the EU, Pfizer’s Trexall and generic versions are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, registration, and compliance, visit PharmaTradz. We facilitate efficient market access for methotrexate tablets, ensuring adherence to European and American standards for safe, effective autoimmune and oncological therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Methotrexate Tablet is used to treat certain types of cancer, severe psoriasis, and rheumatoid arthritis. It works by interfering with the growth of rapidly dividing cells, such as cancer cells, and by suppressing the immune system to reduce inflammation in autoimmune conditions.
Methotrexate Tablet contains the active ingredient methotrexate, a folate antagonist that inhibits the enzyme dihydrofolate reductase. This inhibition prevents DNA synthesis and cell replication, making it effective in slowing or stopping the growth of abnormal cells.
The trade names for Methotrexate include Trexall, Rheumatrex, and Methoblastin, depending on the country and manufacturer.
Methotrexate Tablets are manufactured by several pharmaceutical companies, including Pfizer, Teva Pharmaceuticals, and Sandoz.
The generic name of this product is Methotrexate.
The brand names of Methotrexate include Trexall, Rheumatrex, and Methoblastin.
Methotrexate Tablets are manufactured in multiple countries, including the United States, Germany, and India, by companies such as Pfizer, Teva, and Sandoz, depending on regional market supply.
Related Products
Pegloticase Injecatble
Strength:
8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details
Febuxostat Tablets
Strength:
40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details
Allopurinol Tablets
Strength:
100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
